Wednesday, March 3, 2021


Home General News Jail for woman who failed drug treatment order | The Examiner

Jail for woman who failed drug treatment order | The Examiner

news, local-news,

A woman’s decision to make off owing $12.70 on a taxi fare precipitated a series of events that resulted in her being sentenced in the Launceston Magistrates Court to 24 weeks in jail. Sherridan Keisha Weavell, 20, of Ravenswood, was sentenced to a drug treatment order in November 2019 for dishonesty offences with a six-month custodial component to apply if she did not fulfil the terms of the order. IN OTHER NEWS: Police prosecutor Hamish Woodgate told the court that Weavell used a false name when she caught a taxi to an address in Lambert Street, Ravenswood in January 2020. After paying $10 she told the driver to drive further down the street and promised to get the remaining $12.70 from inside a nearby house….

Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

Inconsistent policing of family violence order breaches is reducing trust in the scheme: report

The ACT Government has released the review into the Family Violence Act. Photo: File. Capricious police responses to family violence orders (FVO), the exclusion...

Space startup Gitai raises $17.1M to help build the robotic workforce of commercial space – Yahoo Finance Australia

Japanese space startup Gitai has raised a $17.1 million funding round, a Series B financing for the robotics startup. This new funding will be used for...

Brumbies batter Waratahs in record mauling

The Brumbies have consigned the NSW Waratahs to their second record loss in as many weeks with a 61-10 Super Rugby AU stampede...

Healthcare Australia CEO stands aside following incorrect COVID-19 vaccine dosages in Brisbane – SBS News

Healthcare Australia's CEO has agreed to stand down following an incident that saw two elderly people in Brisbane given excessive doses of the Pfizer COVID-19 vaccine...

You might also like ...

Covid-19 vaccines: How Moderna, Pfizer/BioNTech, and Johnson & Johnson are preparing for variants
Glib response to Aged Care Royal Commission portends another failed roadmap